Sapir Pharmaceuticals

Trinidad & Tobago
New Jersey, Saint Patrick, Trinidad and Tobago, 08701

Company profile

Sapir Pharmaceuticals company profile

Sapir Pharmaceuticals is developing therapies in Opiate and Cocaine Addiction, withdrawal and relapse, and Novel Pharmaceutical Formulations.

Business identity

Contact email
[email protected]
Phone number
347-407-3864
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
08701
Country code
TT
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$450,000
Last funding
Pre Seed / $450,000 / 2017-08-06
Last equity funding
Pre Seed / $450,000

Founders and investors

No public relation records are available.